TDSPharm Co Ltd
KOSDAQ:464280
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TDSPharm Co Ltd
KOSDAQ:464280
|
KR |
|
B
|
Baidu Inc
XMUN:B1CB
|
CN |
|
Altitude Minerals Ltd
ASX:ATT
|
AU |
|
A
|
Antofagasta PLC
XMUN:FG1
|
UK |
|
Reliance Worldwide Corporation Ltd
F:0EU
|
AU |
|
P
|
Prada SpA
XMUN:PRP
|
IT |
|
NeuroOne Medical Technologies Corp
NASDAQ:NMTC
|
US |
|
R
|
Reach PLC
F:MRR
|
UK |
|
F
|
Fresenius SE & Co KGaA
F:FRE
|
DE |
|
A
|
Antofagasta PLC
F:FG1
|
UK |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
B
|
Boeing Co
XMUN:BCO
|
US |
Bankruptcy Probability
TDSPharm Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Jun 30, 2026 | 20.2B |
| Mar 31, 2026 | 20.2B |
| Dec 31, 2025 | 20.2B |
| Sep 30, 2025 | 30.2B |
| Jun 30, 2026 | 54.5m |
| Mar 31, 2026 | 54.5m |
| Dec 31, 2025 | 54.5m |
| Sep 30, 2025 | 31.1m |
| Jun 30, 2026 | 7.7B |
| Mar 31, 2026 | 7.7B |
| Dec 31, 2025 | 7.7B |
| Sep 30, 2025 | 6.4B |
Solvency Ratios
Solvency Ratios Comparison
TDSPharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
T
|
TDSPharm Co Ltd
KOSDAQ:464280
|
23.3B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
665.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
371.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
253.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
175.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
189.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
131.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
TDSPharm Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, TDSPharm Co Ltd has total debt of 7.7B KRW. This includes both short-term (7.6B KRW) and long-term (62.5m KRW) debt.
You can find a full breakdown on its Balance Sheet.